Search
Isatoribine
go.drugbank.com/drugs/DB04860ExperimentalIsatoribine is a selective agonist of TLR7.
Categories: Nucleic Acids, Nucleotides, and NucleosidesLexibulin
go.drugbank.com/drugs/DB05147InvestigationalCYT997 is an orally available vascular targeting and cytotoxic agent that has proven effective in animal models of a wide range of tumour types including breast, prostate and colon, as well as some leukemias
D-Proline
go.drugbank.com/drugs/DB02853ExperimentalD-proline is an isomer of the naturally occurring amino acid, L-Proline. D-amino acids have been found in relatively high abundance in human plasma and saliva [A19262]. … These amino acids may be of bacterial origin, but there is also evidence that they are endogenously produced through amino acid racemase activity [A19263].
Otilonium
go.drugbank.com/drugs/DB13500InvestigationalMixtures: BROMURO DE OTILONIO + SIMETICONA 40MG + 200MG, SIMFLAT 40MG/80 MG FİLM KAPLI TABLET, 90 ADETCategories: Alimentary Tract and Metabolism, Calcium-Regulating Hormones and AgentsGlypromate
go.drugbank.com/drugs/DB05633ExperimentalIn December 2008, the company discontinued further development of the drug after it failed to show an observable effect. … glycine-proline glutamate), a naturally occurring small-molecule neuroprotectant derived from IGF-1 which inhibits caspase III dependent apoptosis, for the potential treatment of neurodegenerative diseases by
Categories: Amino Acids, Peptides, and ProteinsPreviously treated with an HCV regimen containing an NS5A inhibitor Chronic hepatitis C genotype 2
go.drugbank.com/conditions/DBCOND0093775Drugs: VoxilaprevirSynonyms: Previously treated with an HCV regimen containing an NS5A inhibitor Chronic hepatitis C genotype 2Previously treated with an HCV regimen containing an NS5A inhibitor Chronic hepatitis C genotype 5
go.drugbank.com/conditions/DBCOND0093778Drugs: VoxilaprevirSynonyms: Previously treated with an HCV regimen containing an NS5A inhibitor Chronic hepatitis C genotype 5Multipotent adult arogenitor cells
go.drugbank.com/drugs/DB15742InvestigationalMultiStem is an intravenously-administered, off-the-shelf proprietary product developed which comprises Multipotent Adult Progenitor Cells (MAPCs). … Currently, MultiStem is being investigated against neurological, inflammatory, immune, and cardiovascular diseases and conditions.